DAMELIO FRANK A

SEC source: 0001628280-26-055777 · wk-form4_1786481555.xml · nonDerivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,808

SEC source: 0001628280-26-034643 · wk-form4_1778704519.xml · nonDerivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,458

F1 · price: The Price reported in Table I, Column 4 is the price at which these shares were purchased in a single transaction.

SEC source: 0001194004-26-000006 · form4.xml · derivative · entry 3

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,750

Underlying: Common Stock · 8,750 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F4 · shares: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

F4 · price: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

F4 · derivative.exercise_date: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

F4 · derivative.expiration_date: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

SEC source: 0001194004-26-000004 · form4.xml · derivative · entry 3

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,499.0518 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F4 · shares: As previously reported, on 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.8406 dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25, 80.5989 dividend equivalent rights at $22.96 per RSU credited to the reporting person's account on 10/17/25, 94.6123 dividend equivalent rights at $21.44 per RSU credited to the reporting person's account on 01/16/26 vested dividend equivalent rights.

F4 · price: As previously reported, on 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.8406 dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25, 80.5989 dividend equivalent rights at $22.96 per RSU credited to the reporting person's account on 10/17/25, 94.6123 dividend equivalent rights at $21.44 per RSU credited to the reporting person's account on 01/16/26 vested dividend equivalent rights.

F4 · derivative.exercise_date: As previously reported, on 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.8406 dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25, 80.5989 dividend equivalent rights at $22.96 per RSU credited to the reporting person's account on 10/17/25, 94.6123 dividend equivalent rights at $21.44 per RSU credited to the reporting person's account on 01/16/26 vested dividend equivalent rights.

F4 · derivative.expiration_date: As previously reported, on 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.8406 dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25, 80.5989 dividend equivalent rights at $22.96 per RSU credited to the reporting person's account on 10/17/25, 94.6123 dividend equivalent rights at $21.44 per RSU credited to the reporting person's account on 01/16/26 vested dividend equivalent rights.

SEC source: 0001194004-26-000004 · form4.xml · nonDerivative · entry 2

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Merrill Lynch

Disclosed balance after: 47,490.5734

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

F2 · balance_after: The number of shares in column 5 includes 193.9578 vested restricted stock unit ("RSU") dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25, 175.9643 vested RSU dividend equivalent rights at $22.96 per RSU credited to the reporting person's account on 10/17/25, and 206.5585 vested RSU dividend equivalent rights at $21.44 per RSU credited to the reporting person's account on 01/16/26.

SEC source: 0001140361-26-008877 · form4.xml · derivative · entry 5

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,890

Underlying: Common Stock · 15,890 shares

Expires not disclosed

F4 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027.

F4 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027.

SEC source: 0001140361-26-008877 · form4.xml · derivative · entry 4

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 918.455 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on May 12, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11.

F3 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on May 12, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11.

SEC source: 0001140361-26-008877 · form4.xml · derivative · entry 3

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,112 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026.

F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026.

SEC source: 0001140361-26-008877 · form4.xml · nonDerivative · entry 2

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,031

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.

SEC source: 0001140361-26-008877 · form4.xml · nonDerivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,112

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-26-010670 · wk-form4_1771882201.xml · derivative · entry 2

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,620.8453

Underlying: Common Stock · 1,619.3325 shares

Expires not disclosed

F6 · security: Represents deferred stock units granted pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan, and dividend equivalent units automatically issued thereon (each a "DSU" and collectively, "DSUs"). The DSUs are fully vested and will be settled in shares of Zoetis Inc. common stock upon the reporting person's separation from service as a director at Zoetis.

F7 · derivative.exercise_price: Each DSU represents the right to receive one share of Zoetis Inc. common stock.

F5 · price: Upon the vesting of the reporting person's restricted stock units on February 19, 2026, the reporting person received 1,619.3325 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F5 · derivative.exercise_date: Upon the vesting of the reporting person's restricted stock units on February 19, 2026, the reporting person received 1,619.3325 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F4 · derivative.expiration_date: Not applicable.

F8 · balance_after: Includes 10,001.5128 of DSUs previously granted under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan, including dividend units automatically issued thereon, and 1,619.3325 of DSUs granted upon the vesting of the Reporting Person's RSUs on February 19, 2026.

SEC source: 0001628280-26-010670 · wk-form4_1771882201.xml · derivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,619.3325 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F5 · price: Upon the vesting of the reporting person's restricted stock units on February 19, 2026, the reporting person received 1,619.3325 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F3 · derivative.exercise_date: Each RSU vests and is settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 19, 2025.

F4 · derivative.expiration_date: Not applicable.

SEC source: 0001628280-26-009974 · wk-form4_1771552424.xml · derivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,936

Underlying: Common Stock · 1,936 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

SEC source: 0001194004-26-000002 · form4.xml · derivative · entry 2

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,826

Underlying: Humana Common · 766 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

SEC source: 0001140361-25-018716 · form4.xml · derivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,112

Underlying: Common Stock · 25,112 shares

Expires not disclosed

F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2026.

F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2026.

SEC source: 0001062993-25-008652 · form4.xml · derivative · entry 3

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,235

Underlying: Common Stock · 14,235 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F4 · shares: On 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/02/26 or the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

F4 · price: On 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/02/26 or the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

F4 · derivative.exercise_date: On 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/02/26 or the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

F4 · derivative.expiration_date: On 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/02/26 or the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

SEC source: 0001062993-25-007104 · form4.xml · derivative · entry 3

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,322.9927 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F4 · shares: As previously reported, on 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which cliff vested on 04/02/25, the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.4780 dividend equivalent rights at $20.67 per RSU credited to the reporting person's account on 07/18/24, 88.3925 dividend equivalent rights at $20.69 per RSU credited to the reporting person's account on 10/18/24, 78.1222 dividend equivalent rights at $23.41 per RSU credited to the reporting person's account on 01/16/25, and 254.9927 vested dividend equivalent rights.

F4 · price: As previously reported, on 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which cliff vested on 04/02/25, the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.4780 dividend equivalent rights at $20.67 per RSU credited to the reporting person's account on 07/18/24, 88.3925 dividend equivalent rights at $20.69 per RSU credited to the reporting person's account on 10/18/24, 78.1222 dividend equivalent rights at $23.41 per RSU credited to the reporting person's account on 01/16/25, and 254.9927 vested dividend equivalent rights.

F4 · derivative.exercise_date: As previously reported, on 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which cliff vested on 04/02/25, the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.4780 dividend equivalent rights at $20.67 per RSU credited to the reporting person's account on 07/18/24, 88.3925 dividend equivalent rights at $20.69 per RSU credited to the reporting person's account on 10/18/24, 78.1222 dividend equivalent rights at $23.41 per RSU credited to the reporting person's account on 01/16/25, and 254.9927 vested dividend equivalent rights.

F4 · derivative.expiration_date: As previously reported, on 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which cliff vested on 04/02/25, the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.4780 dividend equivalent rights at $20.67 per RSU credited to the reporting person's account on 07/18/24, 88.3925 dividend equivalent rights at $20.69 per RSU credited to the reporting person's account on 10/18/24, 78.1222 dividend equivalent rights at $23.41 per RSU credited to the reporting person's account on 01/16/25, and 254.9927 vested dividend equivalent rights.

SEC source: 0001062993-25-007104 · form4.xml · nonDerivative · entry 2

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Merrill Lynch

Disclosed balance after: 32,148.189

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

F2 · balance_after: The number of shares in column 5 includes 106.9811 vested restricted stock unit ("RSU") dividend equivalent rights at $20.67 per RSU credited to the reporting person's account on 07/18/24, 106.8777 vested RSU dividend equivalent rights at $20.69 per RSU credited to the reporting person's account on 10/18/24, and 94.4596 vested RSU dividend equivalent rights at $23.41 per RSU credited to the reporting person's account on 01/16/25.

SEC source: 0001555280-25-000124 · wk-form4_1740086503.xml · derivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,596

Underlying: Common Stock · 1,596 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

SEC source: 0001555280-25-000083 · wk-form4_1739311987.xml · derivative · entry 2

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,857.404

Underlying: Common Stock · 1,225.4023 shares

Expires not disclosed

F6 · security: Represents deferred stock units granted pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan, and dividend equivalent units automatically issued thereon (each a "DSU" and collectively, "DSUs"). The DSUs are fully vested and will be settled in shares of Zoetis Inc. common stock upon the reporting person's separation from service as a director at Zoetis.

F7 · derivative.exercise_price: Each DSU represents the right to receive one share of Zoetis Inc. common stock.

F5 · price: Upon the vesting of the reporting person's restricted stock units on February 8, 2025, the reporting person received 1,225.4023 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F5 · derivative.exercise_date: Upon the vesting of the reporting person's restricted stock units on February 8, 2025, the reporting person received 1,225.4023 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F4 · derivative.expiration_date: Not applicable.

F8 · balance_after: Includes 8,632.0017 of DSUs previously granted under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan, including dividend units automatically issued thereon, and 1,225.4023 of DSUs granted upon the vesting of the Reporting Person's RSUs on February 8, 2025.

SEC source: 0001555280-25-000083 · wk-form4_1739311987.xml · derivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,225.4023 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F5 · price: Upon the vesting of the reporting person's restricted stock units on February 8, 2025, the reporting person received 1,225.4023 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F3 · derivative.exercise_date: Each RSU vests and is settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, February 8, 2022.

F4 · derivative.expiration_date: Not applicable.

SEC source: 0001555280-25-000045 · wk-form4_1739197493.xml · derivative · entry 3

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,632.0017

Underlying: Common Stock · 1,236.2125 shares

Expires not disclosed

F8 · security: Represents deferred stock units granted pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan, and dividend equivalent units automatically issued thereon (each a "DSU" and collectively, "DSUs"). The DSUs are fully vested and will be settled in shares of Zoetis Inc. common stock upon the reporting person's separation from service as a director at Zoetis.

F9 · derivative.exercise_price: Each DSU represents the right to receive one share of Zoetis Inc. common stock.

F5 · price: Upon the vesting of the reporting person's restricted stock units on February 6, 2025, the reporting person received 1,236.2125 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F5 · derivative.exercise_date: Upon the vesting of the reporting person's restricted stock units on February 6, 2025, the reporting person received 1,236.2125 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F4 · derivative.expiration_date: Not applicable.

F10 · balance_after: Includes 7,395.7892 of DSUs previously granted under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan, including dividend units automatically issued thereon, and 1,236.2125 of DSUs granted upon the vesting of the Reporting Person's RSUs on February 6, 2025.

SEC source: 0001555280-25-000045 · wk-form4_1739197493.xml · derivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,236.2125 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F5 · price: Upon the vesting of the reporting person's restricted stock units on February 6, 2025, the reporting person received 1,236.2125 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F3 · derivative.exercise_date: Each RSU vests and is settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 6, 2024.

F4 · derivative.expiration_date: Not applicable.

SEC source: 0001062993-25-000103 · form4.xml · derivative · entry 2

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,060

Underlying: Humana Common · 783 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

SEC source: 0000950170-24-137717 · ownership.xml · nonDerivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: On December 18, 2024, Creek Parent, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), dated as of February 5, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger").

F2 · shares: Includes restricted stock units ("RSUs").

F3 · price: At the effective time of the Merger (the "Effective Time"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $63.50 in cash, without interest (the "Merger Consideration").

F4 · price: At the Effective Time, each RSU, whether or not vested, outstanding immediately prior to the Effective Time vested (if unvested) and was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer common stock subject to the RSU multiplied by (ii) the Merger Consideration, except for certain RSUs granted following the date of the Merger Agreement which were converted at the Effective Time into restricted cash awards equal to the product of (a) the Merger Consideration multiplied by (b) the number of shares of Issuer common stock subject to such award and otherwise remain subject to their terms, including vesting and acceleration terms.

SEC source: 0001596783-24-000107 · wk-form4_1730495653.xml · nonDerivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,635

F1 · shares: The equity acquired by the reporting person is the annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-employee director compensation program. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on the earlier of (i) a "change in control" (as defined in the Catalent, Inc. 2018 Omnibus Incentive Plan) and (ii) one year from the date of award, subject to continued service.

F2 · balance_after: Includes restricted stock units.

SEC source: 0001062993-24-010235 · form4.xml · derivative · entry 3

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,068

Underlying: Common Stock · 14,068 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F4 · shares: On 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/10/25 or the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

F4 · price: On 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/10/25 or the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

F4 · derivative.exercise_date: On 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/10/25 or the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

F4 · derivative.expiration_date: On 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/10/25 or the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

SEC source: 0001062993-24-008359 · form4.xml · derivative · entry 3

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,389.9376 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F3 · shares: As previously reported, on 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which cliff vested on 04/10/24, the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 120.9959 dividend equivalent rights at $16.87 per RSU credited to the reporting person's account on 07/14/23, 123.8592 dividend equivalent rights at $16.48 per RSU credited to the reporting person's account on 10/13/23, and 135.0825 dividend equivalent rights at $16.37 per RSU credited to the reporting person's account on 01/11/24. The number of derivative securities in column 5 also reflects 379.9376 vested dividend equivalent rights.

F3 · price: As previously reported, on 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which cliff vested on 04/10/24, the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 120.9959 dividend equivalent rights at $16.87 per RSU credited to the reporting person's account on 07/14/23, 123.8592 dividend equivalent rights at $16.48 per RSU credited to the reporting person's account on 10/13/23, and 135.0825 dividend equivalent rights at $16.37 per RSU credited to the reporting person's account on 01/11/24. The number of derivative securities in column 5 also reflects 379.9376 vested dividend equivalent rights.

F3 · derivative.exercise_date: As previously reported, on 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which cliff vested on 04/10/24, the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 120.9959 dividend equivalent rights at $16.87 per RSU credited to the reporting person's account on 07/14/23, 123.8592 dividend equivalent rights at $16.48 per RSU credited to the reporting person's account on 10/13/23, and 135.0825 dividend equivalent rights at $16.37 per RSU credited to the reporting person's account on 01/11/24. The number of derivative securities in column 5 also reflects 379.9376 vested dividend equivalent rights.

F3 · derivative.expiration_date: As previously reported, on 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which cliff vested on 04/10/24, the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 120.9959 dividend equivalent rights at $16.87 per RSU credited to the reporting person's account on 07/14/23, 123.8592 dividend equivalent rights at $16.48 per RSU credited to the reporting person's account on 10/13/23, and 135.0825 dividend equivalent rights at $16.37 per RSU credited to the reporting person's account on 01/11/24. The number of derivative securities in column 5 also reflects 379.9376 vested dividend equivalent rights.

SEC source: 0001062993-24-008359 · form4.xml · nonDerivative · entry 2

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Merrill Lynch

Disclosed balance after: 17,389.9376

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

SEC source: 0001555280-24-000167 · wk-form4_1707862108.xml · derivative · entry 3

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,316.7437

Underlying: Common Stock · 1,463.3937 shares

Expires not disclosed

F9 · security: Represents deferred stock units granted pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan, and dividend equivalent units automatically issued thereon (each a "DSU" and collectively, "DSUs"). The DSUs are fully vested and will be settled in shares of Zoetis Inc. common stock upon the reporting person's separation from service as a director at Zoetis.

F10 · derivative.exercise_price: Each DSU represents the right to receive one share of Zoetis Inc. common stock.

F5 · price: Upon the vesting of the reporting person's restricted stock units on February 10, 2024, the reporting person received 1,463.3937 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F5 · derivative.exercise_date: Upon the vesting of the reporting person's restricted stock units on February 10, 2024, the reporting person received 1,463.3937 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F4 · derivative.expiration_date: Not applicable.

F11 · balance_after: Includes 5,853.3500 of DSUs previously granted under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan, including dividend units automatically issued thereon, and 1,463.3937 of DSUs granted upon the vesting of the Reporting Person's RSUs on February 10, 2024.

SEC source: 0001555280-24-000167 · wk-form4_1707862108.xml · derivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,212.3053

Underlying: Common Stock · 1,463.3937 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F5 · price: Upon the vesting of the reporting person's restricted stock units on February 10, 2024, the reporting person received 1,463.3937 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. The RSUs vest as follows: 1,463.3937 RSUs vested on February 10, 2024; and 1,212.3053 RSUs will vest on February 8, 2025.

F4 · derivative.expiration_date: Not applicable.

F6 · balance_after: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, February 8, 2022; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

SEC source: 0001555280-24-000139 · wk-form4_1707778662.xml · derivative · entry 4

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,853.35

Underlying: Common Stock · 1,493.2652 shares

Expires not disclosed

F10 · security: Represents deferred stock units granted pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan, and dividend equivalent units automatically issued thereon (each a "DSU" and collectively, "DSUs"). The DSUs are fully vested and will be settled in shares of Zoetis Inc. common stock upon the reporting person's separation from service as a director at Zoetis.

F11 · derivative.exercise_price: Each DSU represents the right to receive one share of Zoetis Inc. common stock.

F5 · price: Upon the vesting of the reporting person's restricted stock units on February 8, 2024, the reporting person received 1,493.2652 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F5 · derivative.exercise_date: Upon the vesting of the reporting person's restricted stock units on February 8, 2024, the reporting person received 1,493.2652 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F4 · derivative.expiration_date: Not applicable.

F12 · balance_after: Includes 4,360.0848 of DSUs previously granted under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan, including dividend units automatically issued thereon, and 1,493.2652 of DSUs granted upon the vesting of the Reporting Person's RSUs on February 8, 2024.

SEC source: 0001555280-24-000139 · wk-form4_1707778662.xml · derivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,493.2652 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F5 · price: Upon the vesting of the reporting person's restricted stock units on February 8, 2024, the reporting person received 1,493.2652 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 8, 2023; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

SEC source: 0001555280-24-000074 · wk-form4_1707427943.xml · derivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,223

Underlying: Common Stock · 1,223 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

SEC source: 0001062993-24-000108 · form4.xml · derivative · entry 5

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 430

Underlying: Humana Common · 430 shares

Expires not disclosed

F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/24.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/24.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/24.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/24.

SEC source: 0001596783-23-000151 · wk-form4_1698785936.xml · nonDerivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,972

F1 · shares: The equity acquired by the reporting person is the annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-employee director compensation program. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award, subject to continued service.

F2 · balance_after: Includes restricted stock units.

SEC source: 0001596783-23-000113 · wf-form4_169343448530734.xml · nonDerivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 979

F1 · shares: The equity acquired by the reporting person is the regular, annual grant of restricted stock units (pro-rated to reflect a partial year of service) provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award.

F2 · balance_after: Represents restricted stock units.

SEC source: 0001062993-23-010586 · form4.xml · derivative · entry 2

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,010

Underlying: Common Stock · 17,010 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · shares: On 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/05/24 or the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

F2 · price: On 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/05/24 or the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

F2 · derivative.exercise_date: On 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/05/24 or the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

F2 · derivative.expiration_date: On 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/05/24 or the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of his service as a member of the Issuer's Board of Directors.

SEC source: 0001062993-23-008947 · form4.xml · derivative · entry 2

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,444 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · shares: As previously reported, on 01/10/23, the reporting person was granted 3,444 restricted stock units ("RSUs"), all of which cliff vested on 04/05/23, the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · price: As previously reported, on 01/10/23, the reporting person was granted 3,444 restricted stock units ("RSUs"), all of which cliff vested on 04/05/23, the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · derivative.exercise_date: As previously reported, on 01/10/23, the reporting person was granted 3,444 restricted stock units ("RSUs"), all of which cliff vested on 04/05/23, the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · derivative.expiration_date: As previously reported, on 01/10/23, the reporting person was granted 3,444 restricted stock units ("RSUs"), all of which cliff vested on 04/05/23, the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

SEC source: 0001062993-23-008947 · form4.xml · nonDerivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,444

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001555280-23-000094 · wf-form4_167641134911625.xml · derivative · entry 3

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,321.3527

Underlying: Common Stock · 1,626.8438 shares

Expires not disclosed

F7 · security: Represents deferred stock units granted pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan, and dividend equivalent units automatically issued thereon (each a "DSU" and collectively, "DSUs"). The DSUs are fully vested and will be settled in shares of Zoetis Inc. common stock upon the reporting person's separation from service as a director at Zoetis.

F8 · derivative.exercise_price: Each DSU represents the right to receive one share of Zoetis Inc. common stock.

F4 · price: Upon the vesting of the reporting person's restricted stock units on February 11, 2023, the reporting person received 1,626.8438 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F4 · derivative.exercise_date: Upon the vesting of the reporting person's restricted stock units on February 11, 2023, the reporting person received 1,626.8438 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F3 · derivative.expiration_date: Not applicable.

F9 · balance_after: Includes 2,694.5089 of DSUs previously granted under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan, including dividend units automatically issued thereon, and 1,626.8438 of DSUs granted upon the vesting of the Reporting Person's RSUs on February 11, 2023.

SEC source: 0001555280-23-000094 · wf-form4_167641134911625.xml · derivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,651.9299

Underlying: Common Stock · 1,626.8438 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 1,450.3939 RSUs will vest on February 10, 2024; and 1,201.5360 RSUs will vest on February 8, 2025.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F4 · price: Upon the vesting of the reporting person's restricted stock units on February 11, 2023, the reporting person received 1,626.8438 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

F1 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 1,450.3939 RSUs will vest on February 10, 2024; and 1,201.5360 RSUs will vest on February 8, 2025.

F3 · derivative.expiration_date: Not applicable.

F1 · balance_after: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 1,450.3939 RSUs will vest on February 10, 2024; and 1,201.5360 RSUs will vest on February 8, 2025.

SEC source: 0001555280-23-000053 · wf-form4_167607155581615.xml · derivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,480

Underlying: Common Stock · 1,480 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). RSUs vest and are settled in shares of Zoetis common stock on the first anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

SEC source: 0001062993-23-000884 · form4.xml · derivative · entry 2

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,444

Underlying: Common Stock · 3,444 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · shares: On 01/10/23, the reporting person was granted 3,444 Restricted Stock Units ("RSUs"), all of which will cliff vest on the earlier of 05/05/23 or the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · price: On 01/10/23, the reporting person was granted 3,444 Restricted Stock Units ("RSUs"), all of which will cliff vest on the earlier of 05/05/23 or the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · derivative.exercise_date: On 01/10/23, the reporting person was granted 3,444 Restricted Stock Units ("RSUs"), all of which will cliff vest on the earlier of 05/05/23 or the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · derivative.expiration_date: On 01/10/23, the reporting person was granted 3,444 Restricted Stock Units ("RSUs"), all of which will cliff vest on the earlier of 05/05/23 or the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

SEC source: 0001062993-23-000199 · form4.xml · derivative · entry 6

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 380

Underlying: Humana Common · 380 shares

Expires not disclosed

F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/23.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/23.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/23.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/23.

SEC source: 0001225208-22-003723 · doc4.xml · derivative · entry 4

DAMELIO FRANK A · CIK 0001194004 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 127,160 shares

Expires 2022-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-22-003723 · doc4.xml · nonDerivative · entry 3

DAMELIO FRANK A · CIK 0001194004 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 555,941

F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

SEC source: 0001225208-22-003723 · doc4.xml · nonDerivative · entry 2

DAMELIO FRANK A · CIK 0001194004 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 615,311

F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

F3 · price: Price is the closing price of Pfizer common stock on February 25, 2022.

SEC source: 0001225208-22-003723 · doc4.xml · nonDerivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 649,918

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

SEC source: 0001225208-22-003466 · doc4.xml · derivative · entry 6

DAMELIO FRANK A · CIK 0001194004 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,516

Underlying: Common Stock · 111,516 shares

Expires 2029-02-24

F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.